These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10461946)

  • 1. Immunological characterization of antigens released by Trypanosoma cruzi-infected cells.
    Grijalva MJ; Goodrum KJ; Rowland EC
    J Parasitol; 1999 Aug; 85(4):663-71. PubMed ID: 10461946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies. Purification and molecular characterization of an 83-kilodalton amastigote protein.
    Pan AA; McMahon-Pratt D
    J Immunol; 1989 Aug; 143(3):1001-8. PubMed ID: 2501384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
    Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
    Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
    Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
    Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An age-related gamma delta T cell suppressor activity correlates with the outcome of autoimmunity in experimental Trypanosoma cruzi infection.
    Cardillo F; Falcão RP; Rossi MA; Mengel J
    Eur J Immunol; 1993 Oct; 23(10):2597-605. PubMed ID: 8405060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection.
    Graefe SE; Jacobs T; Wächter U; Bröker BM; Fleischer B
    Parasite Immunol; 2004 Jan; 26(1):19-28. PubMed ID: 15198642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of antigens of Trypanosoma cruzi which induce antibodies during experimental Chagas' disease.
    Grögl M; Kuhn RE
    J Parasitol; 1985 Apr; 71(2):183-91. PubMed ID: 3923183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites.
    Marinho CR; Nuñez-Apaza LN; Martins-Santos R; Bastos KR; Bombeiro AL; Bucci DZ; Sardinha LR; Lima MR; Alvarez JM
    Scand J Immunol; 2007; 66(2-3):297-308. PubMed ID: 17635807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma cruzi: expression of antigens on the membrane surface of parasitized cells.
    Araujo FG
    J Immunol; 1985 Dec; 135(6):4149-54. PubMed ID: 3934275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The surface protein superfamily of Trypanosoma cruzi stimulates a polarized Th1 response that becomes anergic.
    Millar AE; Wleklinski-Lee M; Kahn SJ
    J Immunol; 1999 May; 162(10):6092-9. PubMed ID: 10229851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agglutination of Trypanosoma cruzi in infected cells treated with serum from chronically infected mice.
    Wendelken JL; Rowland EC
    J Parasitol; 2009 Apr; 95(2):337-44. PubMed ID: 18922039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi: acute infection affects expression of alpha-2-macroglobulin and A2MR/LRP receptor differently in C3H and C57BL/6 mice.
    Soeiro Mde N; Paiva MM; Waghabi MC; Meirelles Mde N; Lorent K; Henriques-Pons A; Coutinho CM; Van Leuven F; Araújo-Jorge TC
    Exp Parasitol; 2000 Oct; 96(2):97-107. PubMed ID: 11052868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chagasic serum contains antibodies capable of inhibiting Trypanosoma cruzi egress from tissue culture cells.
    Costales J; Rowland EC
    J Parasitol; 2005 Aug; 91(4):950-3. PubMed ID: 17089772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
    Nickell SP; Sharma D
    Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection.
    Covarrubias C; Cortez M; Ferreira D; Yoshida N
    Int J Parasitol; 2007 Dec; 37(14):1609-16. PubMed ID: 17640647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
    Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R
    Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily.
    Millar AE; Kahn SJ
    Exp Parasitol; 2000 Feb; 94(2):84-91. PubMed ID: 10673344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi: the expansion of NK, T, and NKT cells in the experimental infection.
    Antúnez MI; Cardoni RL
    Exp Parasitol; 2004; 106(3-4):85-94. PubMed ID: 15172215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.